SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Infoblox, Inc. and Certain Officers - BLOX

NEW YORK, NY--(Marketwired - Jul 18, 2014) - Pomerantz LLP has filed a class action lawsuit against Infoblox, Inc ("Infoblox" or the "Company") ( NYSE : BLOX ) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 5:14-cv-02644, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired securities of Infoblox between September 6, 2013 and February 10, 2014, both dates inclusive (the "Class Period"). This class action seeks to recover damages against the Company and certain of its officers and directors as a result of alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

If you are a shareholder who purchased Infoblox securities during the Class Period, you have until July 29, 2014 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

Infoblox develops, markets, and sells automated network control solutions worldwide. Its appliance-based solution combines real-time IP address management with the automation of network control, and network change and configuration management processes in physical and virtual appliances.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business and operations. Specifically, Defendants made numerous statements regarding Infoblox's financial strength that were false and misleading in light of Defendants' concealment of the fats that: (i) the Company's Federal business prospects were weak and would continue to be weak for the foreseeable future; (ii) the Company had been implementing enormous discounting in order to maintain market share; and (iii) the Company was failing to close on big-ticket deals that had previously driven its revenue growth.

Infoblox insiders -- including the Individual Defendants -- sold significant amounts of Company stock at artificially inflated prices, reaping considerable profits at a time when these individuals were privy to material adverse information concerning the Company's financial prospects. The Individual Defendants and other directors and senior executives sold their shares after publicly providing guidance that they knew or should have known was baseless and unreasonable. Infoblox management further delayed correcting their previously-issued guidance in order to continue to sell shares at inflated prices.

On February 10, 2014, after the market close, Infoblox provided preliminary fiscal second quarter ("2Q") 2014 results and updated its outlook for fiscal year 2014. For the first time, the Company disclosed that it had been "discounting enormously to get deals." The Company revised its guidance downward both for its second quarter ending January 31, 20014 and for its fiscal year ending July 31, 2014. The Company announced that it now predicted revenue of $60 to $61 million for 2Q 2014, down from the previous expectation of $65 to $66 million and a non-GAAP earnings per share ("EPS") of $0.10 to $0.12, versus previous estimates of $0.09 to $0.11. For its full year outlook, Infoblox revised external revenue projections to $250 to $254 million, down from previous guidance over the last two quarters of $270 to $276 million. EPS was updated to be $0.30 to $0.34 diluted earnings per share, lower than previous guidance over the last two quarters for full year earnings of $0.44 to $0.54.

On this news, shares of Infoblox declined $15.95 per share, or over 48.12%, to close at $17.19 per share on February 11, 2014.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com .

CONTACT: Robert S. Willoughby Pomerantz LLP Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 14

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 19

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 18

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 17

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 20

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 15

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 10

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 18

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Flying Bikes Market Expansion: A Journey to New Heights

Updated Category News Views 155

Flying Bikes Market Growth Projections The global flying bikes market is currently on an impressive trajectory. Originally valued at US$ 80.6 billion, it is anticipated to reach an astounding US$ 377.5 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 18.7% during this period. Innovative Performance Metrics Driving Demand Performance metrics for...

Continue Reading
Diversified Energy Enhances Portfolio with New Acquisition Deal

Updated Category News Views 205

Acquisition of Natural Gas Properties by Diversified Energy Bolt-on Acquisition Increases Coal Mine Methane Environmental Credit Cash Flow, Expands Midstream Infrastructure, and Enhances Southern Appalachia Prices Strategic Refinance Incorporates 40% Improvement in Cash Flow from New Hedges and an Innovative Master Trust Structure Solidifies Diversified as the Leading...

Continue Reading
MetroCity Bankshares and First IC Corporation Merge for Growth

Updated Category News Views 129

Strategic Merger of MetroCity Bankshares and First IC Corporation MetroCity Bankshares, Inc. (NASDAQ: MCBS) announced an exciting development as it has secured all necessary regulatory approvals for its merger with First IC Corporation (OTCEM: FIEB). This strategic combination aims to enhance their banking services and expand their operational footprint across several...

Continue Reading
Crown's Revenue Surges in First Quarter Financial Update

Updated Category News Views 178

Crown Electrokinetics Corp. Financial Performance Update Crown Electrokinetics Corp. (NASDAQ: CRKN) has recently released its financial results, marking significant developments for the first quarter of 2025. This summary includes insights into revenue growth, operational accomplishments, and strategic advancements that highlight the company’s evolving presence in the...

Continue Reading
Eileen Revamps Retail Dynamics with New Investment Boost

Updated Category News Views 6

Capital Surge Fuels Eileen's Ambitious Expansion Now, here's something that's bound to shake up the retail tech scene. Eileen Inc., a fresh face in retail technology, just grabbed a strategic investment from DisPact Ventures. This isn't just another drop in the bucket; it's throwing serious weight into their operations to gear up for a monstrous scale. The injection into...

Continue Reading